HK Stock MarketDetailed Quotes

KINTOR PHARMA-B (09939)

Watchlist
  • 2.330
  • +0.010+0.43%
Trading Jan 16 13:08 CST
1.16BMarket Cap-6.35P/E (TTM)

KINTOR PHARMA-B (09939) Key Financial Indicators

09939 Earnings per Share (EPS)

According to the latest financial report of KINTOR PHARMA-B, the latest earnings per share (TTM) for the company is -0.21. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: HKD

Cumulative Quarterly

Loading...

09939 Book Value Per Share (BVPS)

Analyzing a company's fundamentals? Check out KINTOR PHARMA-B's latest financial report to see how much their book value per share (BVPS) is currently at 0.53.

Currency: HKD

Cumulative Quarterly

Loading...

09939 Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of KINTOR PHARMA-B shows that the company's current ratio is 0.44, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

09939 Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of KINTOR PHARMA-B, the quick ratio is 0.42, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

09939 Return on Equity (ROE)

Want to learn more about the financial health of KINTOR PHARMA-B? The latest ROE figure is -32.94%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

09939 Return on Assets (ROA)

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of KINTOR PHARMA-B, the total asset return on investment (ROA) is -18.52%.

Currency: CNY

Cumulative Quarterly

Loading...

09939 Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check KINTOR PHARMA-B's latest financial report to see how their gross margin is doing - currently at -3.28%.

Currency: CNY

Cumulative Quarterly

Loading...

09939 Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of KINTOR PHARMA-B, the net profit margin is -1.39K%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
View More
New Consumption Stocks
View More
Hong Kong stocks continue to recover! The Hang Seng Index briefly returned to 26,000 points.
Recently, Hong Kong stocks have rebounded from their lows, with the three major indices continuing their upward momentum. The Hang Seng Inde Show More